Menu

Blog

Page 7613

Apr 23, 2020

Work on Goodenough’s breakthrough solid-state EV battery moves forward

Posted by in categories: innovation, transportation

Goodenought’s breakthrough on a solid-state battery could mean the end of internal-combustion cars. The job of commercializing it goes to Hydro-Québec.

Apr 23, 2020

IMMORTALISTS MAGAZINE’s 4th PUBLICATION!

Posted by in categories: biotech/medical, economics, evolution, life extension

Dinorah Delphin has unveiled another magnificent issue of the Immortalists Magazine. She has clearly focused her contributing authors on the world pandemic, with impressive results.

One of the outstanding articles is from our pal, the Chairman of the USTP, Gennady Stolyarov. Gennady levels an eviscerating attack on the American health care system.

I can see that Gennady has a visceral reaction to mass death. There is passionate, broiling anger in the lines of his article. He seems to be mounting a crusade, and I’m going to confess that I’m considering arming myself for battle.

Continue reading “IMMORTALISTS MAGAZINE’s 4th PUBLICATION!” »

Apr 23, 2020

Neuralink: Elon Musk unveils brain microchip to let humans ‘merge with computers’

Posted by in categories: biotech/medical, Elon Musk, robotics/AI, space travel

Elon Musk has unveiled plans to implant computer chips in people’s brains that the US billionaire says will treat brain diseases and enable superhuman intelligence.

Neuralink, a secretive company set up by Mr Musk two years ago, has said it plans to begin tests of its “brain-computer interface” technology on humans in the next year.

Mr Musk, 48, the chief executive of Tesla and SpaceX, said the technology will help “solve brain disorders of all kinds” and allow humans to merge with artificial intelligence.

Apr 23, 2020

The proximal origin of SARS-CoV-2

Posted by in category: biotech/medical

Nature Medicine volume 26, pages 450 – 452 (2020) Cite this article.

Apr 23, 2020

Not just the lungs: Some COVID-19 patients show signs of neurological ailments

Posted by in categories: biotech/medical, health, neuroscience

Strokes, seizures, loss of smell and taste and other neurological deficits are showing up in patients critically ill with the coronavirus.

Although the virus is classified as a respiratory disorder and primarily damages the lungs, clinicians are seeing patients with a wide array of symptoms, from seizures to hallucinations, brain inflammation, disorientation, delirium and loss of smell and taste.

“I had a patient, a young guy, 48, who attended a party in New Rochelle two weeks before and came in with hallucinations and confusion,” said Dr. Pooia Fattahi, regional chair of neurology for Trinity Health Of New England. The patient had no fever and only a slight cough. Still, aware some COVID-19 patients show up at hospitals with seizures, strokes and confusion, Fattahi suspected, correctly, that the patient had COVID-19. Three of those who attended the same New Rochelle party ultimately died of the virus.

Apr 23, 2020

Starbleed bug impacts FPGA chips used in data centers, IoT devices, industrial equipment

Posted by in category: computing

Xilinx 7-series and some 6-series FPGAs deemed vulnerable to new Starbleed vulnerability.

Apr 23, 2020

How to live when nobody dies

Posted by in categories: life extension, robotics/AI

Three score and ten is so 1970s. Today, the average baby born in the UK will live long enough to see the beginning of the 22nd century. Increasingly we also hear claims of longevity breakthroughs that could propel those children – and maybe even their parents – into triple digits and beyond. Is eternal life something we want outside of science fiction? And how will society cope if it is?

“The first ten million years were the worst,” said Marvin. “The second ten million years, they were the worst, too. The third ten million years I didn’t enjoy at all. After that I went into a bit of a decline.”

So opines Marvin, Douglas Adams’ paranoid android, who follows the protagonists of ‘The Hitchhiker’s Guide to the Galaxy’ around like a bumbling, grumbling storm cloud. Functionally immortal (and cursed with a “brain the size of a planet”), Marvin is the hubristic dream of eternal life printed and stamped in circuitry. While his human shipmates stumble from one disaster to another, devoting their limited talents to avoiding death at all costs, Marvin plods glumly along, bemoaning the pointlessness of an infinite existence in which there is nothing new to learn, no challenge to his intellect and in which everyone – even his closest friend, a rat that nested for a time in his foot – dies. Except him.

Apr 23, 2020

Computer decodes neural mysteries to restore touch to paralyzed limbs

Posted by in categories: biotech/medical, computing, neuroscience

Researchers have found a way to decode neural signals and transform them back into movement and touch sensation for paralyzed patients.

Apr 23, 2020

You may have seen this chart in my last newsletter

Posted by in category: biotech/medical

Via Harvard David Sinclair “You may have seen this chart in my last newsletter, but it’s believed a bats’ ability to keep their inflammatory response down is one of the reasons they are able to harbor many types of viruses. Most coronavirus-related deaths in humans are due to the immune system response in the body going haywire in its response, not damage caused by the virus itself.

Part 2: https://buff.ly/2VuHGTx


You may have seen this chart in my last newsletter, but it’s believed a bats’ ability to keep their inflammatory response down is one of the reasons they are able to harbor many types of viruses. Most coronavirus-related deaths in humans are due to the immune system response in the body going haywire in its response, not damage caused by the virus itself.

Continue reading “You may have seen this chart in my last newsletter” »

Apr 23, 2020

Antimalarials widely used against COVID-19 heighten risk of cardiac arrest. How can doctors minimize the danger?

Posted by in category: biotech/medical

Treating COVID-19 patents with hydroxychloroquine, a derivative of chloroquine generally thought to have less severe side effects, has become standard at many hospitals. The drug is often combined with the antibiotic azithromycin, which some studies suggest also has antiviral effects. The U.S. Food and Drug Administration has authorized emergency use of both chloroquine and hydroxychloroquine for COVID-19 patients. But no large, randomized trial has proved these drugs—alone or in combination with azithromycin—are effective against the disease.

Cardiologists urge careful monitoring of patients on chloroquine or hydroxychloroquine.